Drug Trial Radar · NCT04139798
Perfluorohexylcotane (NOV03) for the Treatment of Signs and Symptoms of Dry Eye Disease Associated With Meibomian Gland Dysfunction (Gobi Study)
Last checked: Nov 20, 2026Latest source record: Oct 23, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
599
Actual
Start
Jul 20, 2020
Primary completion
Mar 12, 2021
Study completion Mar 12, 2021
Sponsor
- Lead sponsor
- Bausch & Lomb IncorporatedIndustry
- Sponsor type
- Industry
- First posted
- Oct 25, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This trial will evaluate the efficacy, safety, and tolerability of NOV03 ophthalmic solution in comparison to a saline control for the treatment of the signs and symptoms of Dry Eye Disease (DED) associated with Meibomian Gland Dysfunction (MGD).
Conditions
- Dry Eye Disease (DED)
Interventions
NOV03Drug
100% Perfluorohexyloctane
PlaceboDrug
Saline solution (0.6% sodium chloride solution)
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change From Baseline (CFB) in Total Corneal Fluorescein Staining (tCFS) at Day 57Time frame: Assessed from Baseline to Day 57
- Change From Baseline of Dryness Score at Day 57Time frame: Assessed from Baseline to Day 57
Locations
29 sites in 1 country. Site status is shown where the registry gives one.
Bausch Site 124
Birmingham, Alabama
Bausch Site 125
Scottsdale, Arizona
Bausch Site 110
Glendale, California
Bausch Site 121
Long Beach, California
Bausch Site 102
Mission Hills, California
Bausch Site 101
Newport Beach, California
Bausch Site 116
Rancho Cordova, California
103
Torrance, California
Bausch Site 123
Torrance, California
Bausch Site 127
Danbury, Connecticut
Bausch Site 129
Fort Myers, Florida
Bausch Site 115
Jacksonville, Florida
Bausch Site 106
Largo, Florida
Bausch Site 117
Tampa, Florida
Bausch Site 108
Lake Villa, Illinois
Bausch Site 112
Indianapolis, Indiana
Bausch Site 119
Edgewood, Kentucky
Bausch Site 126
Winchester, Massachusetts
Bausch Site 113
Kansas City, Missouri
Bausch Site 111
St Louis, Missouri
Bausch Site 128
Slingerlands, New York
Bausch Site 114
Raleigh, North Carolina
Bausch Site 122
Cranberry Township, Pennsylvania
Bausch Site 107
Memphis, Tennessee
Bausch Site 109
Nashville, Tennessee
Bausch Site 120
El Paso, Texas
Bausch Site 104
Lakeway, Texas
Bausch Site 105
Round Rock, Texas
Bausch Site 118
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.